99 related articles for article (PubMed ID: 26516814)
1. The Location and Distribution of Transurethral Bulking Agent: 3-Dimensional Ultrasound Study.
Yune JJ; Quiroz L; Nihira MA; Siddighi S; O'Leary DE; Santiago A; Shobeiri SA
Female Pelvic Med Reconstr Surg; 2016; 22(2):98-102. PubMed ID: 26516814
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound Evaluation of the Urethra and Bladder Neck Before and After Transurethral Bulking.
Unger CA; Barber MD; Walters MD
Female Pelvic Med Reconstr Surg; 2016; 22(2):118-22. PubMed ID: 26829349
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.
Hegde A; Smith AL; Aguilar VC; Davila GW
Int Urogynecol J; 2013 Jul; 24(7):1151-9. PubMed ID: 23229417
[TBL] [Abstract][Full Text] [Related]
4. Role of three-dimensional ultrasound in assessment of women undergoing urethral bulking agent therapy.
Poon CI; Zimmern PE
Curr Opin Obstet Gynecol; 2004 Oct; 16(5):411-7. PubMed ID: 15353951
[TBL] [Abstract][Full Text] [Related]
5. Radiographic Misdiagnoses After Periurethral Bulking Agents.
Gaines N; Gupta P; Khourdaji AS; Ehlert M; Parikh K; Kohli H; Sirls LT
Female Pelvic Med Reconstr Surg; 2018; 24(4):312-314. PubMed ID: 28657999
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of urethrovesical junction mobility by perineal ultrasonography in stress urinary incontinence.
Demirci F; Kuyumcuoglu U; Uludogan M; Gorgen H; Sahinoglu Z; Delikara MN
J Pak Med Assoc; 1996 Jan; 46(1):2-5. PubMed ID: 8830164
[TBL] [Abstract][Full Text] [Related]
7. Durability of Macroplastique volume and configuration in women with stress urinary incontinence secondary to intrinsic sphincter deficiency: A retrospective review.
Carroll TF; Christie A; Foreman M; Kuprasertkul A; Khatri G; Zimmern PE
Low Urin Tract Symptoms; 2021 Jul; 13(3):335-340. PubMed ID: 33354906
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional transrectal ultrasound of the male urethral rhabdosphincter.
Strasser H; Pinggera GM; Gozzi C; Horninger W; Mitterberger M; Frauscher F; Bartsch G
World J Urol; 2004 Nov; 22(5):335-8. PubMed ID: 15375627
[TBL] [Abstract][Full Text] [Related]
9. [Changes in values of urethral closure pressure and its position after Burch colposuspension--predictive value of MUCP and VLPP for successful rate of this operation].
Martan A; Masata J; Svabík K; Drahorádová P; Pavlíková M
Ceska Gynekol; 2006 May; 71(3):209-19. PubMed ID: 16768049
[TBL] [Abstract][Full Text] [Related]
10. Two Cases of Suspected Rejection of Polydimethylsiloxane Urethral Bulking Agent.
Bennett AT; Lukacz ES
Female Pelvic Med Reconstr Surg; 2017; 23(3):e10-e11. PubMed ID: 27918341
[TBL] [Abstract][Full Text] [Related]
11. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence.
Pannek J; Brands FH; Senge T
J Urol; 2001 Oct; 166(4):1350-3. PubMed ID: 11547072
[TBL] [Abstract][Full Text] [Related]
12. The 'iris effect': how two-dimensional and three-dimensional ultrasound can help us understand anti-incontinence procedures.
Dietz HP; Wilson PD
Ultrasound Obstet Gynecol; 2004 Mar; 23(3):267-71. PubMed ID: 15027016
[TBL] [Abstract][Full Text] [Related]
13. Correlation of tape location and tension with surgical outcome after transobturator suburethral tape procedures.
Yang JM; Yang SH; Huang WC; Tzeng CR
Ultrasound Obstet Gynecol; 2012 Apr; 39(4):458-65. PubMed ID: 21919102
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of bulking agent injection for persistent incontinence in cases of neurogenic bladder dysfunction.
De Vocht TF; Chrzan R; Dik P; Klijn AJ; De Jong TP
J Urol; 2010 Feb; 183(2):719-23. PubMed ID: 20022056
[TBL] [Abstract][Full Text] [Related]
15. Vaginal vs. transabdominal ultrasonography in the evaluation of female urinary tract anatomy, stress urinary incontinence and pelvic organs static disturbances.
Jolić V; Gilja I
Zentralbl Gynakol; 1997; 119(10):483-91. PubMed ID: 9361397
[TBL] [Abstract][Full Text] [Related]
16. [Transurethral injection of polyacrylamide hydrogel (Bulkamid) for the treatment of female stress urinary inkontinence and changes in the cure rate over time].
Martan A; Masata J; Svabík K; El-Haddad R; Hubka P
Ceska Gynekol; 2011 Dec; 76(6):476-81. PubMed ID: 22312846
[TBL] [Abstract][Full Text] [Related]
17. Treatment of postoperative male urinary incontinence using transurethral macroplastique injections.
Kylmälä T; Tainio H; Raitanen M; Tammela TL
J Endourol; 2003 Mar; 17(2):113-5. PubMed ID: 12689406
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between urethral mobility and maximal urethral closure pressure and Valsalva leak-point pressure in women with urinary stress incontinence].
Martan A; Masata J; Svabík K; Drahorádová P; Hlásenská J; Pavlíková M
Ceska Gynekol; 2005 Mar; 70(2):123-8. PubMed ID: 15918266
[TBL] [Abstract][Full Text] [Related]
19. [Changes in values of urethral closure pressure and its position after TVT operation--predictive value of MUCP and VLPP for successful rate of this operation].
Martan A; Masata J; Svabík K; Drahorádová P; Pavlíková M; Hlásenská J
Ceska Gynekol; 2005 Sep; 70(5):370-6. PubMed ID: 16180798
[TBL] [Abstract][Full Text] [Related]
20. Bulking agents: a urogynecology perspective.
Zoorob D; Karram M
Urol Clin North Am; 2012 Aug; 39(3):273-7. PubMed ID: 22877709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
